American Invest Hub
  • Politics
  • Investing
  • Business
  • Latest News

American Invest Hub

  • Politics
  • Investing
  • Business
  • Latest News
Investing

Here’s why Hims & Hers stock price has crashed: buy the dip?

by admin March 27, 2025
March 27, 2025
Here’s why Hims & Hers stock price has crashed: buy the dip?

Hims & Hers stock price has imploded this year, erasing some of the gains made in 2024 when it became one of the top-performing companies in the US. HIMS has crashed to $33.35, down by over 54% from its highest point this year. So, why has the telemedicine stock crashed, and what to expect.

Why HIMS stock has plunged

Hims & Hers is a top company that sells healthcare products used by millions of customers in the US. Its strategy is to focus on niche conditions that people have struggled with for years. These conditions include weight loss, hair, anxiety, skin, and sex. Largely, all Americans face at least one of these challenges, giving it a large, addressable market.

The main reason why the Hims stock price has crashed is that its biggest business is under threat. Hims & Hers started offering compounded GLP-1 treatments, which are generic versions of the weight loss products made by companies like Eli Lilly and Novo Nordisk. 

The compounded drugs are effective and much cheaper than those made by large companies. Customers pay about $200 for the drugs sold by Hims, much lower than the $1,000 sold by the larger companies. 

Hims & Hers is also cheaper than other companies in the industry. The average annual cost of its GLP drugs is $1,980, lower than WW’s $2,208, Henry’s $2,864, Noom’s $3,218, and Ro’s $4,583.

Read more: Will the falling Hims & Hers stock price recover in 2025?

The challenge, however, is that Hims & Hers drugs have not been approved by the FDA, which has sued to stop the tirzepatide sales. In a court ruling this month, a judge sided with the FDA, meaning that, in the longer term, Hims could face a challenge. Hims is running adverts and campaigns pressuring the FDA to allow compounding. 

The weight loss division is an important part of Hims business because of its higher margins. Also, unlike other divisions, these customers will remain with the company for a long time. In most cases, stopping to take weight loss products usually leads to more weight gain.

Hims growth has accelerated

The most recent financial results show that Hims & Hers business has surged in the past few quarters, mostly because of its compounded drugs. 

Hims & Hers made over $481 million in the fourth quarter, up by 95% from the same period  year earlier. This led to an annual revenue of $1.5 billion, a 69% annual increase.

The company also made a net profit of $26 million in the fourth quarter and $126 million in the full year. This growth happened as the number of subscribers surged by 45% to 2.2 million. Most of these subscribers are mostly because of its weight loss products. 

Analysts anticipate that this growth will continue in the coming years. The average estimate is that Hims’ revenue will grow by 92% in the first quarter to $535 million and $2.3 billion this year.

Read more: Is the soaring Hims & Hers stock a good investment?

Hims & Hers stock price analysis

HIMS chart by TradingView

The weekly chart shows that the HIMS stock price peaked at $72.9 earlier this year, and has crashed to $33.35. It has remained above the 25-week Exponential Moving Average (EMA), and is above the key support at $25.30 

The HIMS stock has moved inside the ascending channel in the past few weeks. Also, the two lines of the MACD indicator have pointed downwards, while the Relative Strength Index (RSI) have pointed downwards.

Therefore, the stock will likely have a strong bullish breakout when the GLP issue cools in the coming weeks. If this happens, the next key resistance point to watch will be at $50, up by almost 50% from the current level.

The post Here’s why Hims & Hers stock price has crashed: buy the dip? appeared first on Invezz

0
FacebookTwitterGoogle +Pinterest
previous post
Shiba Inu price prediction: megaphone forms as SHIB burn rate surges
next post
Top 4 vulnerable auto stocks to sell after Trump’s pre-Liberation Day tariffs

Related Posts

Energy Fuels Announces Q1-2024 Results, Including Continued Net...

May 4, 2024

Getchell Gold Corp. Announces Warrant Extension and Debt...

May 2, 2024

IAG share price forecast as transatlantic demand starts...

June 2, 2025

USD/RUB: Here’s why the Russian ruble is soaring

April 18, 2025

DJT stock: Trump Media’s dilution and bankruptcy risks...

October 15, 2024

PDAC President: Critical Metals, Raising Capital Take Center...

March 10, 2024

Culpeo Minerals

April 4, 2024

USD/JPY forecast: signal ahead of BoJ and FOMC...

June 16, 2025

TLT ETF forms death cross after Fed’s hawkish...

December 19, 2024

Zoom Video stock is in trouble, but a...

November 22, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest News

    • GMS stock jumps 29% on takeover interest from Home Depot, QXO, analysts raise PTs

      June 22, 2025
    • Japan’s rice price surge: what’s driving it and why it could spark a political crisis

      June 22, 2025
    • BofA raises STOXX 600 target amid resilient global growth, warns on Mideast risks

      June 22, 2025
    • Palantir co-founder: US must prevent Iranian nukes

      June 22, 2025
    • Fed governor Waller advocates for July rate cut amid tariff, labor market outlook

      June 21, 2025

    Categories

    • Business (3,209)
    • Investing (2,537)
    • Latest News (2,000)
    • Politics (1,530)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: americaninvesthub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 americaninvesthub.com | All Rights Reserved